1800 202 8726
MRI before biopsy

Can an MRI — Avoid a Prostate Biopsy?

For some men, the honest answer is yes. A multiparametric MRI of the prostate, read using the PI-RADS scoring system, can be enough to safely defer a biopsy — and for many others it makes any biopsy that follows far more accurate and lower-risk.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • MRI first, biopsy second — Major guidelines now recommend MRI before prostate biopsy. For some men, that MRI is all that is needed for now.
  • PI-RADS decides — The score your radiologist gives the scan is the number your urologist uses to decide whether biopsy is still needed.
  • Biopsy carries real risk — Infection, including sepsis, is the main reason men want to avoid biopsy. A low PI-RADS score can legitimately support deferring it.
  • Your urologist makes the call — The MRI does not replace the conversation with your specialist. It changes what that conversation is about.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

For men with a raised PSA and a PI-RADS 1 or 2 MRI result, EAU and NICE guidance supports active monitoring without immediate biopsy. The scan does not guarantee no cancer is present. A low PI-RADS result substantially lowers the likelihood of a clinically significant cancer being missed.

When is MRI enough to avoid a biopsy?

EAU and NICE guidance now recommends a multiparametric MRI before prostate biopsy for men with a raised PSA who have not had a prior biopsy. When that MRI returns a PI-RADS 1 or 2 result — meaning no suspicious area is found, or a very low-probability one — active monitoring without immediate biopsy is a supported option.

This is not a guarantee you are clear of cancer. It means the probability of a clinically significant cancer is low enough that the risks and discomfort of biopsy are not currently justified.

If your PSA continues to rise or your symptoms change, your urologist will reassess. A decision to defer biopsy is not permanent — it is a clinical judgement made with the information available now.

What do the PI-RADS numbers on your MRI report mean?

PI-RADS 1
Very low likelihood of a clinically significant cancer. No suspicious area was found on the MRI.
PI-RADS 2
Low likelihood. A change was noted but is unlikely to represent significant cancer. EAU and NICE guidance supports watching rather than proceeding to biopsy in most cases.
PI-RADS 3
Equivocal — the result is uncertain. Your urologist will weigh your PSA level, PSA density, age and family history before deciding whether biopsy is needed.
PI-RADS 4
High likelihood of a clinically significant cancer. Biopsy is typically recommended by all major guidelines.
PI-RADS 5
Very high likelihood. Biopsy is strongly recommended. The MRI report will describe the location of the suspicious area so it can be targeted precisely.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Does biopsy carry an infection risk, and does MRI reduce it?

The main risk from a prostate biopsy is infection. The traditional route — through the back passage — carries a small but real risk of serious infection, including sepsis requiring hospital admission. The transperineal route, through the skin between the legs, has a substantially lower infection rate and is now preferred in many UK and European centres.

MRI before biopsy reduces risk in two ways. It limits the number of cores your urologist needs to take, and it allows the biopsy to target the suspicious area rather than sampling the whole gland. Fewer needle passes means fewer entry points for bacteria.

Ask your urologist which route is used at your centre and what infection-prevention steps are in place. You are entitled to a clear answer, and your preference matters.

Did you know?

In prospective trials, adding MRI before biopsy allowed a substantial proportion of men with raised PSA to safely defer the procedure, without missing clinically significant cancers.

The men who avoided biopsy were not being undertreated. Their risk, confirmed on imaging, was genuinely low.

Source: PRECISION Trial, New England Journal of Medicine; EAU Guidelines on Prostate Cancer

Explore 133 more Biopsy by Body Part topics

HUB — Biopsy by Body Part

All Biopsy by Body Part →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

If my PI-RADS score is 3, do I still need a biopsy?

A PI-RADS 3 result is genuinely uncertain — the radiologist cannot confidently call it significant or insignificant. Your urologist will use additional information: your PSA level, PSA density, age, family history and any prior biopsy results. Some men with a PI-RADS 3 result are offered a repeat MRI in a few months; others proceed to a targeted biopsy. There is no single rule that applies to everyone, and this is exactly the kind of decision your specialist is trained to make with you.

How accurate is MRI at detecting prostate cancer?

MRI is reliable at detecting clinically significant prostate cancer — the kind that needs treatment — and less reliable at finding very small or low-grade cancers that would not have changed your management anyway. No imaging test is perfect. A reassuring MRI lowers the probability of missing something important, but it does not eliminate it. This is why your urologist continues to monitor your PSA even after a low PI-RADS result, rather than simply discharging you.

Can I ask for an MRI before a biopsy is offered?

Yes, and it is a reasonable thing to ask. EAU and NICE guidance both recommend MRI before biopsy as standard care for men with a raised PSA who have not had a prior biopsy. If your urologist has not mentioned it, ask directly: should I have an MRI before we decide about a biopsy? The answer may depend on your PSA level, your age and local availability, but the question itself is well within current clinical practice.

Does the MRI for prostate cancer need a contrast injection?

Multiparametric MRI, the type most commonly used to assess the prostate, typically includes a contrast injection alongside other sequences. Some centres now use biparametric MRI, which omits the injection, and evidence is growing that this is adequate for most patients. Your team will tell you which type is planned. If you have kidney disease, a contrast allergy or any concern about the injection, tell your team before the scan is booked so they can plan accordingly.

What happens between an MRI result and a possible biopsy?

Your MRI images are scored by a radiologist using the PI-RADS system. The report goes to your urologist, who will discuss the result with you and explain what they recommend next. If biopsy is still needed, the MRI images guide the biopsy needles to the specific area that concerned the radiologist — this is called targeted or fusion biopsy. The interval between scan and a decision is typically one to two weeks, though it varies by centre.

Is there a biopsy route with a lower infection risk?

The transperineal route — where biopsy needles pass through the skin between the legs rather than through the back passage — is associated with a substantially lower infection rate than the traditional transrectal approach, and is now preferred in many centres. If infection risk concerns you, ask your urologist which route is used at your centre and what preventive steps are taken. The answer will vary by centre. Requesting the transperineal route where it is available is a legitimate and reasonable thing to discuss.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation